Bejel Treatment Market

Bejel is an infectious rare disease that belongs to spirochete treponema pallidum bacterium family. The organisms cause ulceration (lesions) on mucous membrane (skin), particularly in or near mouth. Also, these organisms progress gradually appear on arms, legs and bones that convert Bejel to most severe stages. Bejel treatment has other symptoms such as lymph nodes or swollen glands, groin and skin ulceration around the rectum. The transmission of these infections is by means skin contact and through common use of drinking & eating utensils. Bejel infection is familiar to syphilis but it is not transmitted sexually. Other related disorders that can be similar to bejel treatment symptoms are Pinta, Yams and Syphilis.
Bejel Treatment Market contains market size and forecasts of Bejel Treatment in Global, including the following market information:
Global Bejel Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bejel Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Benzathine Penicillin G Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bejel Treatment include Pfizer, APP Pharmaceuticals, Abcam plc., Baxter International Inc., King Pharmaceuticals Inc., Physicians Total Care Inc., Alembic IT Department, ECPlaza Network Inc and Sandoz International GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bejel Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bejel Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bejel Treatment Market Segment Percentages, by Type, 2021 (%)
Benzathine Penicillin G
Doxycycline
Tetracycline
Global Bejel Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bejel Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Ambulatory Surgery Centers
Drug Stores
Online Pharmacy
Global Bejel Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bejel Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bejel Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bejel Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
APP Pharmaceuticals
Abcam plc.
Baxter International Inc.
King Pharmaceuticals Inc.
Physicians Total Care Inc.
Alembic IT Department
ECPlaza Network Inc
Sandoz International GmbH
Triveni Interchem Private Limited
CSPC Pharmaceuticals Group Ltd
Semisyntech Co. Ltd
CSC Pharmaceuticals International
Merck KGaA